134 related articles for article (PubMed ID: 17351397)
1. Antitumor properties of diastereomeric and geometric analogs of vitamin D3.
Wietrzyk J; Chodyński M; Fitak H; Wojdat E; Kutner A; Opolski A
Anticancer Drugs; 2007 Apr; 18(4):447-57. PubMed ID: 17351397
[TBL] [Abstract][Full Text] [Related]
2. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
3. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines.
Opolski A; Wietrzyk J; Chrobak A; Marcinkowska E; Wojdat E; Kutner A; Radzikowski C
Anticancer Res; 1999; 19(6B):5217-22. PubMed ID: 10697538
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
Wietrzyk J; Nevozhay D; Milczarek M; Filip B; Kutner A
Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
[TBL] [Abstract][Full Text] [Related]
6. Antitumor properties of (5E,7E) analogs of vitamin D3.
Filip B; Milczarek M; Wietrzyk J; Chodyński M; Kutner A
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):399-402. PubMed ID: 20227499
[TBL] [Abstract][Full Text] [Related]
7. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
Wietrzyk J; Pełczyńska M; Madej J; Dzimira S; Kuśnierczyk H; Kutner A; Szelejewski W; Opolski A
Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
[TBL] [Abstract][Full Text] [Related]
8. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative Activity and in Vivo Toxicity of Double-Point Modified Analogs of 1,25-Dihydroxyergocalciferol.
Trynda J; Turlej E; Milczarek M; Pietraszek A; Chodyński M; Kutner A; Wietrzyk J
Int J Mol Sci; 2015 Oct; 16(10):24873-94. PubMed ID: 26492238
[TBL] [Abstract][Full Text] [Related]
10. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
Campbell MJ; Reddy GS; Koeffler HP
J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity of side-chain truncated vitamin D analogs (PRI-1203 and PRI-1204) against human malignant melanoma cell lines.
Piotrowska A; Wierzbicka J; Kwiatkowska K; Chodyński M; Kutner A; Żmijewski MA
Eur J Pharmacol; 2020 Aug; 881():173170. PubMed ID: 32445704
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Biological Activity of Diastereomeric and Geometric Analogs of Calcipotriol, PRI-2202 and PRI-2205, Against Human HL-60 Leukemia and MCF-7 Breast Cancer Cells.
Milczarek M; Chodyński M; Filip-Psurska B; Martowicz A; Krupa M; Krajewski K; Kutner A; Wietrzyk J
Cancers (Basel); 2013 Oct; 5(4):1355-78. PubMed ID: 24202449
[TBL] [Abstract][Full Text] [Related]
14. The influence of 1,25-dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 on alphavbeta3 integrin expression in cancer cell lines.
Wietrzyk J; Filip B; Milczarek M; Klopotowska D; Maciejewska M; Dabrowska K; Kurzepa A; Dzimira S; Madej J; Kutner A
Oncol Rep; 2008 Oct; 20(4):941-52. PubMed ID: 18813838
[TBL] [Abstract][Full Text] [Related]
15. Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines.
de Vos S; Holden S; Heber D; Elstner E; Binderup L; Uskokovic M; Rude B; Chen DL; Le J; Cho SK; Koeffler HP
Prostate; 1997 May; 31(2):77-83. PubMed ID: 9140119
[TBL] [Abstract][Full Text] [Related]
16. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
Yoon JS; Kim JY; Park HK; Kim ES; Ahn KS; Yoon SS; Cho CG; Kim BK; Lee YY
Int J Oncol; 2008 Feb; 32(2):387-96. PubMed ID: 18202761
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanisms of superagonistic pro-differentiating activities of side-chain modified analogs of vitamin D2.
Baurska H; Marchwicka A; Kłopot A; Kutner A; Marcinkowska E
Oncol Rep; 2012 Sep; 28(3):1110-6. PubMed ID: 22751936
[TBL] [Abstract][Full Text] [Related]
18. 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.
Nakagawa K; Sasaki Y; Kato S; Kubodera N; Okano T
Carcinogenesis; 2005 Jun; 26(6):1044-54. PubMed ID: 15718253
[TBL] [Abstract][Full Text] [Related]
19. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A.
Rashid SF; Moore JS; Walker E; Driver PM; Engel J; Edwards CE; Brown G; Uskokovic MR; Campbell MJ
Oncogene; 2001 Apr; 20(15):1860-72. PubMed ID: 11313934
[TBL] [Abstract][Full Text] [Related]
20. Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway.
O'Kelly J; Uskokovic M; Lemp N; Vadgama J; Koeffler HP
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):107-16. PubMed ID: 16777406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
